Editorial: Cancer therapy: The challenge of handling a double-edged sword

被引：13
作者：
Nurgali, Kulmira [1 ,2 ,3 ]
Rudd, John A. [4 ,5 ]
Was, Halina [6 ]
Abalo, Raquel [7 ,8 ,9 ,10 ,11 ]
机构：
[1] Victoria Univ, Inst Hlth & Sport, Melbourne, Vic, Australia
[2] Univ Melbourne, Dept Med Western Hlth, Melbourne, Vic, Australia
[3] Australian Inst Musculoskeletal Sci AIMSS, Regenerat Med & Stem Cells Program, Melbourne, Vic, Australia
[4] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China
[5] Chinese Univ Hong Kong, Lab Anim Serv Ctr, Shatin, Hong Kong, Peoples R China
[6] Mil Inst Med, Lab Mol Oncol & Innovat Therapies, Warsaw, Poland
[7] Univ Rey Juan Carlos, Dept Ciencias Basicas Salud, Area Farmacol & Nutr, Alcorcon, Spain
[8] CSIC, Unidad Asociada I D I, IQM, Madrid, Spain
[9] URJC, High Performance Res Grp Physiopathol & Pharmacol, Alcorcon, Spain
[10] Grp Trabajo Ciencias Basicas Dolor & Analgesia So, Madrid, Spain
[11] Grp Trabajo Cannabinoides Soc Espanola Dolor, Madrid, Spain
来源：
FRONTIERS IN PHARMACOLOGY | 2022年 / 13卷
关键词：
cancer; chemotherapy; immunotherapy; side effects; sequelae;
D O I：
10.3389/fphar.2022.1007762
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：5
相关论文
共 20 条
[11]   Interventions for Preventing Cardiotoxicity in Breast Cancer Patients Receiving Trastuzumab: A Systemic Review and Bayesian Network Meta-Analysis [J].
Li, Xinyi ;
Wu, Ziyang ;
Du, Xin ;
Wu, Yibo ;
Xie, Xiaohui ;
Shi, Luwen .
FRONTIERS IN PHARMACOLOGY, 2021, 12
[12]   Hepatic Arterial Infusion Chemotherapy of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Sorafenib as Initial Treatment for Advanced Hepatocellular Carcinoma [J].
Liang, Run-Bin ;
Zhao, Yang ;
He, Min-Ke ;
Wen, Dong-Sheng ;
Bu, Xiao-Yun ;
Huang, Ye-Xing ;
Lai, Zhi-Cheng ;
Xu, Yu-Jie ;
Kan, Anna ;
Wei, Wei ;
Zhang, Yao-Jun ;
Chen, Min-Shan ;
Guo, Rong-Ping ;
Li, Qi-Jiong ;
Shi, Ming .
FRONTIERS IN ONCOLOGY, 2021, 11
[13]  
Nurgali K., 2018, ADVERSE EFFECTS OF CANCER CHEMOTHERAPY: ANYTHING NEW TO IMPROVE TOLERANCE AND REDUCE SEQUELAE ?, DOI DOI 10.3389/978-2-88945-482-2
[14]   Escape From Cisplatin-Induced Senescence of Hypoxic Lung Cancer Cells Can Be Overcome by Hydroxychloroquine [J].
Olszewska, Aleksandra ;
Borkowska, Agata ;
Granica, Monika ;
Karolczak, Justyna ;
Zglinicki, Bartosz ;
Kieda, Claudine ;
Was, Halina .
FRONTIERS IN ONCOLOGY, 2022, 11
[15]   Pulmonary Toxicities Associated With the Use of Immune Checkpoint Inhibitors: An Update From the Immuno-Oncology Subgroup of the Neutropenia, Infection & Myelosuppression Study Group of the Multinational Association for Supportive Care in Cancer [J].
Rapoport, Bernardo L. ;
Shannon, Vickie R. ;
Cooksley, Tim ;
Johnson, Douglas B. ;
Anderson, Lindsay ;
Blidner, Ada G. ;
Tintinger, Gregory R. ;
Anderson, Ronald .
FRONTIERS IN PHARMACOLOGY, 2021, 12
[16]   Case Report: Severe Rashes Associated With Fruquintinib in a Patient With Metastatic Colorectal Cancer [J].
Shu, Yefei ;
Zheng, Song .
FRONTIERS IN ONCOLOGY, 2021, 11
[17]   Insights Into Acute and Delayed Cisplatin-Induced Emesis From a Microelectrode Array, Radiotelemetry and Whole-Body Plethysmography Study of Suncus murinus (House Musk Shrew) [J].
Tu, Longlong ;
Liu, Julia Y. H. ;
Lu, Zengbing ;
Cui, Dexuan ;
Ngan, Man P. ;
Du, Peng ;
Rudd, John A. .
FRONTIERS IN PHARMACOLOGY, 2021, 12
[18]   Doxorubicin/Adriamycin Monotherapy or Plus Ifosfamide in First-Line Treatment for Advanced Soft Tissue Sarcoma: A Pooled Analysis of Randomized Trials [J].
Wang, Bi-Cheng ;
Kuang, Bo-Hua ;
Xiao, Bo-Ya ;
Lin, Guo-He .
FRONTIERS IN ONCOLOGY, 2021, 11
[19]   Mechanisms of Chemotherapy-Induced Neurotoxicity [J].
Was, Halina ;
Borkowska, Agata ;
Bagues, Ana ;
Tu, Longlong ;
Liu, Julia Y. H. ;
Lu, Zengbing ;
Rudd, John A. ;
Nurgali, Kulmira ;
Abalo, Raquel .
FRONTIERS IN PHARMACOLOGY, 2022, 13
[20]   The Contribution of Phospholipase C in Vomiting in the Least Shrew (Cryptotis Parva) Model of Emesis [J].
Zhong, Weixia ;
Darmani, Nissar A. .
FRONTIERS IN PHARMACOLOGY, 2021, 12
12